Treatment 3 - BioRePeelCl3® FND + ARES® AK

Описание к видео Treatment 3 - BioRePeelCl3® FND + ARES® AK

BioReTherapy is a complete aesthetic peeling treatment, painless, needle free and suitable for all skin types and areas of face and body. The line is based on BioRePeelCl3® exfoliating power and post-treatment solutions, BioReHydra® Serum and BioReLift Cream, specifically developed for normal, combination, dry and oily skin.

BioRePeelCl3® FND is a two-phase topical medical device with specific action for face, neck and décolleté.
How BioRePeelCl₃® FND works
The synergy of the individual components of BioRePeelCl3® restores the optimal physio-logical conditions of the skin making the product no longer just a peel, but a complete aes-thetic and dermatological medical treatment, ideal for any medical need thanks to its anti-oxidant and moisturizing action. It is indicated for use on healthy skin, as an adjuvant treatment in the prevention of acne and its scarring results.

BioRePeelCl3® FND promotes a marked exfoliating action on dead cells that amplifies the an-tioxidant and moisturizing effects of amino acids, vitamins and GABA. The action of amino ac-ids, vitamins and GABA is also assisted by the lipophilic phase thanks to its filming and mois-turizing action.

ARES® AK is developed as a metabolic stimulator and moisturizer for the treatment of TIRED LOOKING SKIN and ALL TYPES OF TISSUE SCARRING.
How Ares® AK works
SUCCINIC ACID is produced and concentrated in the mitochondria and its primary biological function is that of a metabolic intermediate. Many metabolic pathways like metabolism of carbohydrates, amino acids, fatty acids, cholesterol, and heme, rely on the temporary formation of succinate. It’s easy to understand that at the cellular level, succinic acid accelerates metabolic processes that promote skin rejuvenation, and can ultimately, help increase skin firmness and elasticity. The stimulating effect is completed by a pool of 14 NATURAL AMINOACIDS and a mixture of high and low molecular weight hyaluronic acids.

Комментарии

Информация по комментариям в разработке